Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Glucose homeostasis in hypertensive subjects.

Korhonen P, Aarnio P, Saaresranta T, Jaatinen P, Kantola I.

Hypertension. 2008 Apr;51(4):945-9. doi: 10.1161/HYPERTENSIONAHA.107.104869. Epub 2008 Feb 19.

2.

Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.

Vyssoulis GP, Liakos CI, Karpanou EA, Triantafyllou AI, Michaelides AP, Tzamou VE, Markou MI, Stefanadis CI.

J Am Soc Hypertens. 2013 Jul-Aug;7(4):294-304. doi: 10.1016/j.jash.2013.02.007. Epub 2013 Apr 3.

PMID:
23562108
3.

Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.

Al-Habori M, Al-Mamari M, Al-Meeri A.

Diabetes Res Clin Pract. 2004 Sep;65(3):275-81.

PMID:
15331208
4.

Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.

Rajala U, Laakso M, Qiao Q, Keinänen-Kiukaanniemi S.

Diabetes Care. 1998 Oct;21(10):1664-9.

PMID:
9773727
5.

Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism.

De Pergola G, Nardecchia A, Cirillo M, Boninfante B, Sciaraffia M, Giagulli VA, Triggiani V, Silvestris F.

Endocr Metab Immune Disord Drug Targets. 2015;15(4):297-301.

PMID:
25944063
6.

Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance.

Rajala U, Qiao Q, Laakso M, Keinänen-Kiukaanniemi S.

Diabetes Res Clin Pract. 2000 Dec;50(3):231-9.

PMID:
11106838
7.

Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74).

Anuradha S, Mohan V, Gokulakrishnan K, Dixit M.

Metabolism. 2010 Jun;59(6):774-9. doi: 10.1016/j.metabol.2009.09.022. Epub 2009 Nov 14.

PMID:
19913849
8.

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent.

Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI, Dar FA.

Diabetes Res Clin Pract. 2000 Feb;47(2):135-46.

PMID:
10670914
9.

[An epidemiological study of abnormal glucose metabolism and its risk factors among middle and aged population with hypertension in Chengdu area].

Yi YJ, Ran X, Huang XB, Liu Y, Zhang TJ, Ouyang LY, Zeng W, Xu JB, Yang L, Liu Y, Li XJ, Zhao SQ.

Zhonghua Nei Ke Za Zhi. 2010 Apr;49(4):301-4. Chinese.

PMID:
20627035
10.

High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population.

Saaristo TE, Barengo NC, Korpi-Hyövälti E, Oksa H, Puolijoki H, Saltevo JT, Vanhala M, Sundvall J, Saarikoski L, Peltonen M, Tuomilehto J.

BMC Public Health. 2008 Dec 29;8:423. doi: 10.1186/1471-2458-8-423.

11.

[The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)].

Łopatyński J, Mardarowicz G, Nicer T, Szcześniak G, Król H, Matej A, Szydłowski W, Paszkowski J, Dabek K, Zmurowska B, Szyprowska-Grzegorczyk E.

Pol Arch Med Wewn. 2001 Sep;106(3):781-6. Polish.

PMID:
11928586
12.

High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children.

Grandone A, Amato A, Luongo C, Santoro N, Perrone L, del Giudice EM.

J Endocrinol Invest. 2008 Dec;31(12):1098-102.

PMID:
19246977
13.

[Fasting or post-challenge blood glucose values for detection of glucose intolerance in screening for metabolic syndrome?].

Jermendy G, Hidvégi T, Hetyési K, Bíró L.

Orv Hetil. 2002 Sep 29;143(39):2247-52. Hungarian.

PMID:
12418378
14.
15.

Impaired fasting glucose and impaired glucose tolerance in rural population of Bangladesh.

Rahim MA, Azad Khan AK, Nahar Q, Ali SM, Hussain A.

Bangladesh Med Res Counc Bull. 2010 Aug;36(2):47-51.

PMID:
21473200
16.

Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.

Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Alviggi L, Gnasso A, Consoli A, Cavalot F, Cavallo MG, Leonetti F, Giaccari A, Del Prato S; GENFIEV Investigators..

Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):699-705. doi: 10.1016/j.numecd.2010.03.006. Epub 2010 Nov 5.

PMID:
21291660
17.

Prevalence and pattern of abnormal glucose tolerance in adult Nigerians with primary hypertension.

Essien OE, Peters EJ, Udoh AE, Ekott JU, Odigwe CO.

Niger J Med. 2007 Jan-Mar;16(1):50-6.

PMID:
17563969
18.

Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.

Vinciguerra F, Baratta R, Farina MG, Tita P, Padova G, Vigneri R, Frittitta L.

Acta Diabetol. 2013 Jun;50(3):443-9. doi: 10.1007/s00592-013-0460-3. Epub 2013 Feb 28.

PMID:
23447004
19.

Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.

Elbert A, Schreier L, Galli C, Beresan H, Lopez G, Traversa M, Berg G.

J Ren Nutr. 2006 Oct;16(4):300-3.

PMID:
17046613
20.

Supplemental Content

Support Center